Identification of Glycyrrhiza As the Rikkunshito Constituent with the Highest Antagonistic Potential on Heterologously Expressed 5-HT3A Receptors Due to the Action of Flavonoids

Overview

Journal Front Pharmacol

Date 2015 Jul 21

PMID 26191003

Citations 12

Authors

Robin Herbrechter

Paul M Ziemba

Katrin M Hoffmann

Hanns Hatt

Markus Werner

Gunter Gisselmann

Affiliations

Soon will be listed here.

Abstract

The traditional Japanese phytomedicine rikkunshito is traditionally used for the treatment of gastrointestinal motility disorders, cachexia and nausea. These effects indicate 5-HT3 receptor antagonism, due to the involvement of these receptors in such pathophysiological processes. E.g., setrons, specific 5-HT3 receptor antagonists are the strongest antiemetics, developed so far. Therefore, the antagonistic effects of the eight rikkunshito constituents at heterologously expressed 5-HT3Areceptors were analyzed using the two-electrode voltage-clamp technique. The results indicate that tinctures from Aurantii, Ginseng, Zingiberis, Atractylodis and Glycyrrhiza inhibited the 5-HT3A receptor response, whereas the tinctures of Poria cocos, Jujubae and Pinellia exhibited no effect. Surprisingly, the strongest antagonism was found for Glycyrrhiza, whereas the Zingiberis tincture, which is considered to be primarily responsible for the effect of rikkunshito, exhibited the weakest antagonism of 5-HT3A receptors. Rikkunshito contains various vanilloids, ginsenosides and flavonoids, a portion of which show an antagonistic effect on 5-HT3 receptors. A screening of the established ingredients of the active rikkunshito constituents and related substances lead to the identification of new antagonists within the class of flavonoids. The flavonoids (-)-liquiritigenin, glabridin and licochalcone A from Glycyrrhiza species were found to be the most effective inhibitors of the 5-HT-induced currents in the screening. The flavonoids (-)-liquiritigenin and hesperetin from Aurantii inhibited the receptor response in a non-competitive manner, whereas glabridin and licochalcone A exhibited a potential competitive antagonism. Furthermore, licochalcone A acts as a partial antagonist of 5-HT3A receptors. Thus, this study reveals new 5-HT3A receptor antagonists with the aid of increasing the comprehension of the complex effects of rikkunshito.

Citing Articles

Bioelectric medicine: unveiling the therapeutic potential of micro-current stimulation.

Lee H, Cho S, Kim D, Lee T, Kim H Biomed Eng Lett. 2024; 14(3):367-392.

PMID: 38645592 PMC: 11026362. DOI: 10.1007/s13534-024-00366-3.

Research Progress on the Pharmacodynamic Mechanisms of Sini Powder against Depression from the Perspective of the Central Nervous System.

Shen Z, Yu M, Dong Z Medicina (Kaunas). 2023; 59(4).

PMID: 37109699 PMC: 10141708. DOI: 10.3390/medicina59040741.

Anticancer effects of licochalcones: A review of the mechanisms.

Deng N, Qiao M, Li Y, Liang F, Li J, Liu Y Front Pharmacol. 2023; 14:1074506.

PMID: 36755942 PMC: 9900005. DOI: 10.3389/fphar.2023.1074506.

Review on the Diverse Biological Effects of Glabridin.

Zhang J, Wu X, Zhong B, Liao Q, Wang X, Xie Y Drug Des Devel Ther. 2023; 17:15-37.

PMID: 36647530 PMC: 9840373. DOI: 10.2147/DDDT.S385981.

Role of Licochalcone A in Potential Pharmacological Therapy: A Review.

Li M, Xie L, Jiang H, Huang Q, Tong R, Li X Front Pharmacol. 2022; 13:878776.

PMID: 35677438 PMC: 9168596. DOI: 10.3389/fphar.2022.878776.

References

Min K, Koo B, Kang J, Bai S, Ko S, Cho Z . Effect of ginseng saponins on the recombinant serotonin type 3A receptor expressed in xenopus oocytes: implication of possible application as an antiemetic. J Altern Complement Med. 2003; 9(4):505-10. DOI: 10.1089/107555303322284794. View

Barann M, Molderings G, Bruss M, Bonisch H, Urban B, Gothert M . Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol. 2002; 137(5):589-96. PMC: 1573528. DOI: 10.1038/sj.bjp.0704829. View

Hannon J, Hoyer D . Molecular biology of 5-HT receptors. Behav Brain Res. 2008; 195(1):198-213. DOI: 10.1016/j.bbr.2008.03.020. View

Das P, Dillon G . Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. J Pharmacol Exp Ther. 2005; 314(1):320-8. DOI: 10.1124/jpet.104.080325. View

Thompson A, Duke R, Lummis S . Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor. Mol Pharmacol. 2011; 80(1):183-90. PMC: 3127528. DOI: 10.1124/mol.111.071415. View

Cubeddu L, Pendergrass K, Ryan T, York M, Burton G, Meshad M . Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group. Am J Clin Oncol. 1994; 17(2):137-46. DOI: 10.1097/00000421-199404000-00010. View

Ernst E, Pittler M . Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000; 84(3):367-71. DOI: 10.1093/oxfordjournals.bja.a013442. View

Boess F, Martin I . Molecular biology of 5-HT receptors. Neuropharmacology. 1994; 33(3-4):275-317. DOI: 10.1016/0028-3908(94)90059-0. View

Costedio M, Hyman N, Mawe G . Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum. 2007; 50(3):376-88. DOI: 10.1007/s10350-006-0763-3. View

10.

Fujitsuka N, Uezono Y . Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome. Front Pharmacol. 2014; 5:271. PMC: 4261902. DOI: 10.3389/fphar.2014.00271. View

11.

Barann M, Gothert M, Bruss M, Bonisch H . Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn Schmiedebergs Arch Pharmacol. 1999; 360(3):234-41. DOI: 10.1007/s002109900089. View

12.

Lee B, Lee J, Lee S, Jeong S, Yoon I, Lee J . Identification of ginsenoside interaction sites in 5-HT3A receptors. Neuropharmacology. 2007; 52(4):1139-50. DOI: 10.1016/j.neuropharm.2006.12.001. View

13.

Huang Q, Iwamoto M, Aoki S, Tanaka N, Tajima K, Yamahara J . Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger. Chem Pharm Bull (Tokyo). 1991; 39(2):397-9. DOI: 10.1248/cpb.39.397. View

14.

Manteniotis S, Lehmann R, Flegel C, Vogel F, Hofreuter A, Schreiner B . Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia. PLoS One. 2013; 8(11):e79523. PMC: 3832644. DOI: 10.1371/journal.pone.0079523. View

15.

Abdel-Aziz H, Nahrstedt A, Petereit F, Windeck T, Ploch M, Verspohl E . 5-HT3 receptor blocking activity of arylalkanes isolated from the rhizome of Zingiber officinale. Planta Med. 2005; 71(7):609-16. DOI: 10.1055/s-2005-871265. View

16.

Abdel-Aziz H, Windeck T, Ploch M, Verspohl E . Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. Eur J Pharmacol. 2005; 530(1-2):136-43. DOI: 10.1016/j.ejphar.2005.10.049. View

17.

Kim J, Yoon I, Lee B, Choi S, Lee J, Lee J . Effects of Korean red ginseng extract on cisplatin-induced nausea and vomiting. Arch Pharm Res. 2005; 28(6):680-4. DOI: 10.1007/BF02969358. View

18.

Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K . Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008; 134(7):2004-13. DOI: 10.1053/j.gastro.2008.02.078. View

19.

Sherkheli M, Vogt-Eisele A, Bura D, Beltran Marques L, Gisselmann G, Hatt H . Characterization of selective TRPM8 ligands and their structure activity response (S.A.R) relationship. J Pharm Pharm Sci. 2010; 13(2):242-53. DOI: 10.18433/j3n88n. View

20.

Kim Y, Zhao R, Park S, Lee J, Cho I, Yang C . Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol. 2008; 154(1):165-73. PMC: 2438972. DOI: 10.1038/bjp.2008.79. View